1. Synthesis of New Thienyl Ring Containing HIV-1 Protease Inhibitors: Promising Preliminary Pharmacological Evaluation against Recombinant HIV-1 Proteases
- Author
-
Federico Berti, Carlo Bonini, Francesco Tramutola, Paolo Lupattelli, Rocco Pandolfo, Margherita De Bonis, Maria Funicello, Lucia Chiummiento, Nadia Di Blasio, Carlo, Bonini, Lucia, Chiummiento, Margherita De, Boni, Nadia Di, Blasio, Maria, Funicello, Paolo, Lupattelli, Rocco, Pandolfo, Francesco, Tramutola, and Berti, Federico
- Subjects
Proteases ,Stereochemistry ,medicine.medical_treatment ,stereoselectivity ,Structure-Activity Relationship ,HIV Protease ,HIV-1 protease ,HIV protease ,Drug Discovery ,medicine ,HIV Protease Inhibitor ,Protease inhibitor (pharmacology) ,Saquinavir ,Nelfinavir ,Protease ,biology ,Chemistry ,peptidomimetics ,Stereoisomerism ,Biological activity ,HIV Protease Inhibitors ,biochemical phenomena, metabolism, and nutrition ,peptidomimetic ,Recombinant Proteins ,Mutation ,Quinolines ,biology.protein ,Molecular Medicine ,Asparagine ,medicine.drug - Abstract
A series of new thienyl ring containing analogues of nelfinavir and saquinavir with different substitution patterns were synthesized from suitable enantiopure diols. Their inhibitory activity against wild type recombinant HIV-1 protease was evaluated. In general thienyl groups spaced from the core by a methylene group gave products showing IC(50) in the nanomolar range, irrespective of the type and the substitution pattern of the heterocycle. The range of activity of the two most active compounds is substantially maintained or even increased against two commonly selected mutants, under drug pressure, such as V32I and V82A.
- Published
- 2010
- Full Text
- View/download PDF